Repaglinide 1 mg Australia

Description

Introduction

Repaglinide 1 mg Australia contains 1 mg of repaglinide in an oral tablet. It is used to help manage blood glucose in type 2 diabetes. Repaglinide works by encouraging the pancreas to release insulin, particularly in relation to meals.

Diabetes care also involves attention to food, physical activity and blood glucose monitoring. A healthcare professional determines how repaglinide fits an individual treatment plan.

What Is It?

Repaglinide is a medicine in the meglitinide group. Each tablet contains 1 mg of the active ingredient repaglinide. The tablets are taken by mouth. If an allergy or intolerance is a concern, ask a pharmacist to check the complete ingredient list for the tablets dispensed.

Repaglinide is used for type 2 diabetes, a condition in which the body cannot use insulin effectively or does not produce enough to keep blood glucose within the intended range. It is not a substitute for the other parts of diabetes care recommended by a healthcare professional.

How Does It Work?

Food supplies glucose, which enters the bloodstream after eating. Insulin helps move glucose from the blood into the body’s cells. Repaglinide stimulates the pancreas to release insulin and helps lower blood glucose around meals.

The medicine can also lower blood glucose too far, causing hypoglycaemia. Its relationship to meals is an important part of safe treatment. The prescriber considers blood glucose results when assessing whether repaglinide is working as intended.

Common Uses

Repaglinide is used alongside diet and exercise to improve blood glucose control in type 2 diabetes. It may be prescribed on its own or with metformin when metformin alone has not provided sufficient control. The choice of treatment depends on a clinical assessment.

Repaglinide is not used to treat type 1 diabetes or diabetic ketoacidosis. Blood glucose readings and HbA1c tests can help show how well a type 2 diabetes treatment plan is working over time.

Available Strengths

• Repaglinide 0.5 mg Australia
• Repaglinide 1 mg Australia
• Repaglinide 2 mg Australia

Key Features

• Contains 1 mg of repaglinide per oral tablet.
• Used to help manage blood glucose in type 2 diabetes.
• Stimulates insulin release from the pancreas.
• Acts in relation to meals, making meal patterns relevant to treatment.
• Requires awareness of low blood glucose symptoms.

Benefits

• Repaglinide lowers blood glucose by increasing insulin release.
• Its meal-related action can help manage blood glucose rises associated with eating.
• It can be included in a type 2 diabetes plan alongside diet and exercise.
• Blood glucose and HbA1c testing provide ways to assess the response.

The effect varies between individuals and is assessed through ongoing monitoring.

Possible Side Effects

• Low blood glucose, or hypoglycaemia, is an important possible side effect. Symptoms may include sweating, shaking, hunger, dizziness, headache, weakness or changes in mood or behaviour.
• Severe hypoglycaemia can cause confusion, seizures or loss of consciousness and requires urgent medical attention.
• Headache, constipation, diarrhoea, nasal congestion, joint aches and back pain have also been reported.
• Persistent, severe or unexpected symptoms should be discussed with a healthcare professional.

Precautions

• Tell the prescriber about previous low blood glucose episodes or difficulty eating regular meals.
• Repaglinide is not used for type 1 diabetes or diabetic ketoacidosis.
• Liver or kidney disease may affect treatment decisions and monitoring.
• Discuss pregnancy, plans for pregnancy or breastfeeding with a healthcare professional.
• Ask a pharmacist to check the tablet ingredients if you have a known medicine allergy.

Additional Precautions

• Illness and changes in food intake, exercise or alcohol use can affect blood glucose control.
• Low blood glucose may affect concentration and the ability to drive or use machinery. Be familiar with its warning signs and the advice in your care plan.
• Tell healthcare professionals, including dentists, about repaglinide treatment before a procedure.
• Keep the blood glucose checks and follow-up appointments recommended by your healthcare professional.

Storage Instructions

• Keep tablets in their original container, tightly closed and out of the sight and reach of children.
• Store at room temperature, away from excess heat and moisture.
• Avoid keeping tablets in a damp bathroom.
• Check the packaging for any further storage directions. Ask a pharmacist how to dispose of tablets that are no longer needed.

How to Take

• Repaglinide tablets are taken by mouth in relation to meals. Follow the timing and amount on the prescription label.
• Ask a prescriber or pharmacist what to do if a meal is missed or your eating pattern changes.
• Do not change the prescribed amount or stop treatment without discussing it with a healthcare professional.
• If unsure whether a tablet has already been taken, seek advice before taking another.

Drug Interactions

• Gemfibrozil must not be used with repaglinide because it can greatly increase repaglinide exposure and the risk of low blood glucose.
• Some antibiotics, antifungals, corticosteroids and other diabetes medicines can affect repaglinide or blood glucose control.
• Alcohol may increase the risk of low blood glucose.
• Ask a prescriber or pharmacist to review prescription medicines, non-prescription products, vitamins and herbal supplements before treatment changes.

Why Choose This Product?

• The tablet provides 1 mg of repaglinide when that strength has been prescribed.
• Repaglinide has an established role in lowering blood glucose in type 2 diabetes.
• Its response can be assessed with blood glucose monitoring and HbA1c testing.
• A healthcare professional can confirm whether this strength fits the treatment plan.

Frequently Asked Questions (FAQs)

What is the active ingredient?

Each tablet contains 1 mg of repaglinide.

What is repaglinide used for?

It helps manage blood glucose in type 2 diabetes alongside diet and exercise.

Is it used for type 1 diabetes?

No. Repaglinide is not used to treat type 1 diabetes.

How does it lower blood glucose?

It encourages the pancreas to release insulin, which helps lower glucose in the blood.

Can repaglinide cause low blood glucose?

Yes. Sweating, shaking, hunger and dizziness are possible signs. Severe symptoms require urgent medical attention.

Why do meals matter?

Repaglinide acts in relation to meals. Follow the prescription directions and seek advice if your meal pattern changes.

Can it be used with metformin?

Repaglinide may be prescribed with metformin in some type 2 diabetes treatment plans. A clinician decides whether the combination is appropriate.

What if I take other medicines?

Ask a pharmacist or prescriber to review them, including non-prescription products. Gemfibrozil is an important interaction.

How is the response to treatment checked?

Blood glucose readings and HbA1c tests help a healthcare professional assess the effect over time.

Where should the tablets be stored?

Keep them in their original closed container at room temperature, away from excess heat and moisture, and out of children’s reach.